Elicio Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Elicio Therapeutics, Inc. (ELTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $739.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $739.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $834.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $935.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.04M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $739.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $834.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $935.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.15M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.26M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.38M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.51M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.63M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.77M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.90M 10-K · filed 2024-03-29 |
| 2023-09-30 | $2.04M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.16M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $659.00K 10-K · filed 2023-03-17 |
| 2022-09-30 | $750.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $847.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $948.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.05M 10-K · filed 2022-03-30 |
| 2021-09-30 | $1.17M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.29M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |